Cargando…

Peroxiredoxin 6 overexpression regulates adriamycin-induced myocardial injury, oxidative stress and immune response in rats

BACKGROUND: Adriamycin is an anthracycline drug used to treat a variety of tumors. Adriamycin has a much stronger affinity for myocardial tissue than other body tissues. Cancer patients treated with adriamycin are prone to toxic damage to heart tissue. Peroxiredoxin 6 (PRDX6) is a novel antioxidant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jianshu, Cao, Weiping, Chen, Chi, Chen, Xiaohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661857/ https://www.ncbi.nlm.nih.gov/pubmed/33209900 http://dx.doi.org/10.21037/atm-20-6598

Ejemplares similares

Peroxiredoxin 6 overexpression attenuates lipopolysaccharide-induced acute kidney injury
por: Lee, Dong Hun, et al.
Publicado: (2017)

Overexpression of Peroxiredoxin 6 (PRDX6) Promotes the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
por: He, Yan, et al.
Publicado: (2018)

Effects of Peroxiredoxin 6 and Its Mutants on the Isoproterenol Induced Myocardial Injury in H9C2 Cells and Rats
por: Mu, Runhong, et al.
Publicado: (2022)

Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis
por: Jiang, Lai, et al.
Publicado: (2020)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

In vivo oxidative stress alters thiol redox status of peroxiredoxin 1 and 6 and impairs rat sperm quality
por: Liu, Yannan, et al.
Publicado: (2017)

Inhibition of HDAC6 Activity Alleviates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Potential Role of Peroxiredoxin 1 Acetylation and Redox Regulation
por: Leng, Yan, et al.
Publicado: (2018)

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress
por: Whitaker, H C, et al.
Publicado: (2013)

Peroxiredoxin 6 in skin carcinogenesis
por: Rolfs, Frank, et al.
Publicado: (2014)

Peroxiredoxin6 in Endothelial Signaling
por: Patel, Priyal, et al.
Publicado: (2019)

Radioprotective Role of Peroxiredoxin 6
por: Sharapov, Mars G., et al.
Publicado: (2019)

Peroxiredoxin 6 Overexpression Induces Anxiolytic and Depression-Like Behaviors by Regulating the Serotonergic Pathway in Mice
por: Gu, Sun Mi, et al.
Publicado: (2022)

ATRA attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin
por: Zhang, Lei, et al.
Publicado: (2018)

Antioxidants Special Issue: Peroxiredoxin 6 as a Unique Member of the Peroxiredoxin Family
por: Fisher, Aron B.
Publicado: (2019)

Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma
por: Cha, Mee-Kyung, et al.
Publicado: (2009)

The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
por: Hanaka, Tetsuya, et al.
Publicado: (2019)

Fish Peroxiredoxins and Their Role in Immunity
por: Valero, Yulema, et al.
Publicado: (2015)

Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
por: Escribano, Begoña M., et al.
Publicado: (2014)

Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats
por: Liu, Meng-Lin, et al.
Publicado: (2018)

The Role of Peroxiredoxin 6 in Cell Signaling
por: Arevalo, José A., et al.
Publicado: (2018)

Peroxiredoxin 6: The Protector of Male Fertility
por: O’Flaherty, Cristian
Publicado: (2018)

Correction: Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
Publicado: (2014)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Anti-Oxidant and Pro-Oxidant Effects of Peroxiredoxin 6: A Potential Target in Respiratory Diseases
por: Jia, Wenhui, et al.
Publicado: (2023)

Role of C/EBP-α in Adriamycin-induced podocyte injury
por: Zhong, Fang, et al.
Publicado: (2016)

Peroxiredoxins—The Underrated Actors during Virus-Induced Oxidative Stress
por: Karpenko, Inna L., et al.
Publicado: (2021)

Engineering antioxidant ceria-zirconia nanomedicines for alleviating podocyte injury in rats with adriamycin-induced nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2023)

Peroxiredoxin 6 protects irradiated cells from oxidative stress and shapes their senescence-associated cytokine landscape
por: Salovska, Barbora, et al.
Publicado: (2021)

Peroxiredoxin, Senescence, and Cancer
por: Wu, Mengyao, et al.
Publicado: (2022)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Mouse Models of Genetically Altered Peroxiredoxin 6
por: Feinstein, Sheldon I.
Publicado: (2019)

Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells
por: Feng, Fan, et al.
Publicado: (2018)

Inhibition of Peroxiredoxin 6 PLA2 Activity Decreases Oxidative Stress and the Severity of Acute Lung Injury in the Mouse Cecal Ligation and Puncture Model
por: Fisher, Aron B., et al.
Publicado: (2021)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats
por: Zhang, Wei, et al.
Publicado: (2008)

Serial Assessment of Myocardial Properties Using Cyclic Variation of Integrated Backscatter in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Ha, Jong-Won, et al.
Publicado: (2005)

Cardiac peroxiredoxins undergo complex modifications during cardiac oxidant stress
por: Schröder, Ewald, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_upp8trvpjsis1fvg7s6gqp4b0g